Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.059x

Based on the latest financial reports, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a cash flow conversion efficiency ratio of 0.059x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.10 Billion ≈ $2.45 Billion USD) by net assets (€35.38 Billion ≈ $41.36 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Guangzhou Baiyunshan Pharmaceutical Hold (GU5) liquidity interval to measure how many days the company can operate on defensive assets alone.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jiangsu Jinling Sports Equipment Co Ltd SHE:300651	0.053x
Tianjin Jinbin Development SHE:000897	0.007x
Suzhou Jin Hong Shun Auto Parts Co Ltd Class A SHG:603922	-0.006x
Jinsanjiang (Zhaoqing) Silicon Material Company Limited SHE:301059	N/A
Yunnan Yuntou Ecology and Environment Technology Co Ltd SHE:002200	-0.375x
Bandwidth Inc NASDAQ:BAND	0.057x
KT Submarine Co. Ltd KQ:060370	0.022x
Suli Co Ltd SHG:603585	0.074x

Annual Cash Flow Conversion Efficiency for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)

The table below shows the annual cash flow conversion efficiency of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see GU5 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€40.08 Billion ≈ $46.86 Billion	€-232.46 Million ≈ $-271.77 Million	-0.006x	-106.36%
2024-12-31	€37.77 Billion ≈ $44.16 Billion	€3.44 Billion ≈ $4.02 Billion	0.091x	-18.54%
2023-12-31	€36.68 Billion ≈ $42.88 Billion	€4.10 Billion ≈ $4.80 Billion	0.112x	-46.23%
2022-12-31	€33.64 Billion ≈ $39.33 Billion	€7.00 Billion ≈ $8.18 Billion	0.208x	+14.89%
2021-12-31	€31.33 Billion ≈ $36.62 Billion	€5.67 Billion ≈ $6.63 Billion	0.181x	+772.92%
2020-12-31	€28.21 Billion ≈ $32.97 Billion	€585.19 Million ≈ $684.14 Million	0.021x	-89.26%
2019-12-31	€25.99 Billion ≈ $30.38 Billion	€5.02 Billion ≈ $5.87 Billion	0.193x	-14.27%
2018-12-31	€23.14 Billion ≈ $27.06 Billion	€5.22 Billion ≈ $6.10 Billion	0.225x	+136.80%
2017-12-31	€19.26 Billion ≈ $22.52 Billion	€1.83 Billion ≈ $2.14 Billion	0.095x	-33.96%
2016-12-31	€17.65 Billion ≈ $20.64 Billion	€2.54 Billion ≈ $2.97 Billion	0.144x	-35.54%
2015-12-31	€8.68 Billion ≈ $10.15 Billion	€1.94 Billion ≈ $2.27 Billion	0.224x	+1.31%
2014-12-31	€7.92 Billion ≈ $9.26 Billion	€1.75 Billion ≈ $2.04 Billion	0.221x	+15.99%
2013-12-31	€7.02 Billion ≈ $8.21 Billion	€1.34 Billion ≈ $1.56 Billion	0.190x	--

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

F:GU5 Germany Medical Distribution

Market Cap

$413.91 Million

€354.04 Million EUR

Market Cap Rank

#13365 Global

#1386 in Germany

Share Price

€1.61

Change (1 day)

+0.00%

52-Week Range

€1.61 - €2.30

All Time High

€2.30